$456,500,000 in Total Settlement Funds Available. See if you qualify!Find Out More

ImmunityBio, Inc. Settlement
(NASDAQ: IBRX)
Settlement

Claim Deadline: July 07, 2025

Settlement Fund: $10,500,000

Settlement Class

All persons or entities that purchased or acquired ImmunityBio securities during the Settlement Class Period and were damaged thereby. The terms of the Settlement are set forth in a Stipulation of Settlement, dated January 28, 2025.

Important Documents

Settlement Status

Preliminarily Approved

Class Period

March 10, 2021 - August 08, 2023

Settlement Hearing Date

May 23, 2025

Opt-Out Deadline

June 13, 2025

Claims Admin

Epiq 
P.O. Box 2239
Portland, OR 97208-2239
+1 888-853-4782
info@ImmunityBioSecuritiesSettlement.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.